000			05399nam a22005175i 4500
001			978-0-387-72573-4
003			DE-He213
005			20161121230750.0
007			cr nn 008mamaa
008			100301s2008 xxu| s |||| 0|eng d
020			_a9780387725734 _9978-0-387-72573-4
024	7		_a10.1007/978-0-387-72573-4 _2doi
050		4	_aRM1-950
072		7	_aMMG _2bicssc
072		7	_aMED071000 _2bisacsh
082	0	4	_a615 _223
245	1	0	_aNeuroimmune Pharmacology _h[electronic resource] / _cedited by Howard E. Gendelman, Tsuneya Ikezu.
264		1	_aBoston, MA : _bSpringer US, _c2008.
300			_aL, 828 p. 164 illus., 40 illus. in color. _bonline resource.
336			_atext _btxt _2rdacontent
337			_acomputer _bc _2rdamedia
338			_aonline resource _bcr _2rdacarrier
347			_atext file _bPDF _2rda
505	0		_aImmunology of the Nervous System -- Introducing Neuroimmune Pharmacology -- Innate and Adaptive Immunity in Health and Disease -- Anatomical Networks: Structure and Function of the Nervous System -- The Blood Brain Barrier -- Anterior Chamber and Retina -- Hippocampus and Spatial Memory -- Glial and Neuronal Cellular Compostion, Biology, and Physiology -- Astrocytes, Oligodendrocytes, and Schwann Cells -- Macrophages, Microglia, and Dendritic C -- Neuronal and Glial Signaling -- The Vertebrate Retina -- Lymphocytes and the Nervous System -- Stem Cells -- Neurobiology and Neural Systems -- Cytokines and Chemokines -- CNS Cell Signaling -- Nervous System Diseases and Immunity: Clinical Descriptions -- Neurodegeneration -- Multiple Sclerosis and Other Demyelinating Diseases -- Guillain-Barré Syndrome, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, and Axonal Degeneration and Regeneration -- Guillain-Barré Syndrome -- Autoimmune Disease -- NeuroAIDS -- HTLV-I/II -- Viral Encephalitis -- Alzheimer's Disease -- Parkinson's Disease -- Amyotrophic Lateral Sclerosis -- Huntington's Disease -- Prion Diseases -- Glaucoma -- Stroke and Cerebrovascular Disease -- Neurogenesis and Brain Repair -- Familial Neurodegenerative Diseases and Single Nucleotide Polymorphisms -- The Neuroimmune System in Psychiatric Disorders -- Major Depression, Bipolar Syndromes, and Schizophrenia -- Molecular Pathogenesis for Schizophrenia and Major Depression -- Drugs of Abuse and the Immune System -- Therapeutics -- Neuropharmacology -- Neurodegenerative Diseases -- Multiple Sclerosis -- HIV-Associated Dementia -- Immunotherapy -- Alzheimer's Disease -- Parkinson's Disease and Amyotrophic Lateral Sclerosis -- Protective and Regenerative Autoimmunity in CNS Injury -- Adjuvants -- Polymer Nanomaterials -- Gene Therapy and Vaccination -- Proteomics and Genomics -- Neuroimaging.
520			_aThe chapters contained in this volume show scientific relationships among historically separated fields. This allows a unique opportunity for scientists and students to gain broad knowledge in disparate fields of clinical medicine and biomedical research. Overall, the text integrates cutting-edge neuroscience, immunology, pharmacology, neurogenetics, neurogenesis, gene therapy, adjuvant therapy, proteomics, and magnetic resonance imaging. It is a rich harvest and readers will gain a perspective that has not been readily available. Exposure to such a wealth of ideas is bound to inspire readers to undertake new and productive research initiatives. In summary, this is a volume not to be put on the shelf as a reference, but to be read cover to cover by aspiring neuroscientists. Dr. Patrick L. McGeer Professor Emeritus Kinsmen Laboratory of Neurological Research, University of British Columbia This exciting new textbook, Neuroimmune Pharmacology, reflects the history and vision of the Society on NeuroImmune Pharmacology and of the Society’s official publication, the Journal of Neuroimmune Pharmacology. All three represent deliberations arising from a relatively young, interdisciplinary, and dynamic field of research, which have major translational implications for neurodegenerative, neuroinflammatory, neuropsychiatric diseases, and infections of the nervous system. They all demonstrate the synergistic value of integrating the parts: Neuroscience, Immunology, and Pharmacology. The extraordinary accomplishment of Neuroimmune Pharmacology is its comprehensive nature. It will be enthusiastically welcomed by members of the Society and will serve as the definitive resource for all students and researchers interested in various topics that are so well covered in the book. Dr. Phillip K. Peterson President, Society on NeuroImmune Pharmacology Professor, Department of Medicine, University of Minnesota.
650		0	_aMedicine.
650		0	_aHuman physiology.
650		0	_aImmunology.
650		0	_aNeurosciences.
650		0	_aPharmacology.
650		0	_aCell biology.
650	1	4	_aBiomedicine.
650	2	4	_aPharmacology/Toxicology.
650	2	4	_aImmunology.
650	2	4	_aNeurosciences.
650	2	4	_aCell Biology.
650	2	4	_aHuman Physiology.
700	1		_aGendelman, Howard E. _eeditor.
700	1		_aIkezu, Tsuneya. _eeditor.
710	2		_aSpringerLink (Online service)
773	0		_tSpringer eBooks
776	0	8	_iPrinted edition: _z9780387725727
856	4	0	_uhttp://dx.doi.org/10.1007/978-0-387-72573-4
912			_aZDB-2-SBL
950			_aBiomedical and Life Sciences (Springer-11642)
999			_c503663 _d503663